Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05220137 · ClinicalTrials.gov registry record · NA
Using the Multiphase Optimization Strategy to Adapt Cognitive Processing Therapy
A NA study of Stress Disorders, Post-Traumatic, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 3
- Study locations
NCT05220137: Active NA study of Stress Disorders, Post-Traumatic, sponsored by VA Office of Research and Development.
NCT05220137 is a NA study of Stress Disorders, Post-Traumatic that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 270 participants, above the 152-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (78% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05220137, a NA study of Stress Disorders, Post-Traumatic, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 3
- Study locations
Study Summary
Cognitive Processing Therapy (CPT) consists of discrete therapeutic components that are delivered across 12 sessions, but most Veterans never reach session 12, and those who drop out receive only 4 sessions on average. Veterans drop out because of time constraints, logistics, and lack of perceived benefit. Unfortunately, Veterans who drop out prematurely may never receive the most effective components of CPT and continue to experience symptom-related distress and numerous other negative outcomes, including lost productivity, substance use, later-life physical disability, reduced quality of life, and increased risk of suicide. The overall objective of this study is to adapt CPT into a brief, effective format. The rationale is that identifying the most effective intervention components and delivering only those components will make CPT deliverable in a shorter timeframe, thus improving efficiency, reducing drop-out related to poor treatment response, and ensuring that Veterans receive the most beneficial components of treatment, which will significantly improve their quality of life.
Primary Outcome
The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) is a 30-item structured interview used to measure of PTSD severity. In addition to assessing the 20 DSM-5 PTSD symptoms, questions target the onset and duration of symptoms, subjective distress, impact of symptoms on social and occupational functioning and improvement in symptoms since a previous CAPS administration. Scoring An index trauma/Criterion A event At least one Criterion B symptom (questions 1-5) At least one Criterion C symptom
Conditions Studied
Interventions
- BEHAVIORAL Modified A-B-C: Working with Events, Thoughts, and Feelings
- BEHAVIORAL Challenging Questions
- BEHAVIORAL Patterns of Problematic Thinking
- BEHAVIORAL Challenging Beliefs
- BEHAVIORAL Veteran's choice of Module (Safety/Trust/Power and Control/Esteem/Intimacy)
Study Locations (3)
Michigan
- VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor
Ohio
- Cincinnati VA Medical Center, Cincinnati, OH - Cincinnati
Utah
- VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT05220137 still lists
NCT05220137 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, above the 152-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (78% higher).
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 5 interventions - of which Modified A-B-C: Working with Events, Thoughts, and Feelings is the first listed.
NCT05220137 reports a single indexed study location in Michigan, Ohio, Utah.
Frequently Asked Questions
What is clinical trial NCT05220137 about?
NCT05220137 is a clinical study titled "Using the Multiphase Optimization Strategy to Adapt Cognitive Processing Therapy". Cognitive Processing Therapy (CPT) consists of discrete therapeutic components that are delivered across 12 sessions, but most Veterans never reach session 12, and those who drop out receive only 4 sessions on average. Veterans drop out because of time constraints, logistics, and lack of perceived b...
What is the current status of trial NCT05220137?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2022-08-01. Estimated completion is 2026-03-31.
What conditions does trial NCT05220137 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT05220137?
The interventions under investigation include: Modified A-B-C: Working with Events, Thoughts, and Feelings (BEHAVIORAL), Challenging Questions (BEHAVIORAL), Patterns of Problematic Thinking (BEHAVIORAL), Challenging Beliefs (BEHAVIORAL), Veteran's choice of Module (Safety/Trust/Power and Control/Esteem/Intimacy) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05220137?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05220137 being conducted?
This trial has 3 study locations across Michigan, Ohio, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05220137's enrollment target sits among peer trials
270 8th of 66 higher than 59 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI